Okamoto, Ryuji
Kumagai, Eita
Kai, Hisashi
Shibata, Rei
Ohtsubo, Toshio
Kawano, Hiroaki
Fujiwara, Akira
Ito, Masaaki
Fukumoto, Yoshihiro
Arima, Hisatomi
Article History
Received: 17 August 2018
Revised: 7 October 2018
Accepted: 9 October 2018
First Online: 5 April 2019
Conflict of interest
: The Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, received research grants from Bristol-Myers Squibb, MSD K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Daiichi Sankyo Pharmaceutical Co., Ltd., Genzyme Japan, Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Mitsubishi Tanabe Corporation, Otsuka Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., AstraZeneca K.K., and Boehringer Ingelheim Co., Ltd. Rei Shibata received honoraria from Medtoronic, Boehringer Ingelheim, Eli Lilly and Mitsubishi Tanabe Pharma. Toshio Ohtsubo received lecture fees from Sanwa Kagaku Kenkyusho Co., Ltd. Hisashi Kai received lecture fees from Daiichi Sankyo Co Pharmaceutical Co., Ltd., Mitsubishi Tanabe Corporation, Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Masaaki Ito received lecture fees from Daiichi Sankyo Co Pharmaceutical Co., Ltd., Mitsubishi Tanabe Corporation, Bayer Yakuhin, Ltd. and Takeda Pharmaceutical Co., Ltd.